When most people think about sleep apnea, I’d assume they think of snoring. Snoring is just one type of sleep apnea that most ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

Medical conditions that deprive the testes of oxygen, such as sleep apnea, may be contributing to the decline in male fertility observed over the past 50 years, a new study suggests.

Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe ...

Try a single issue or save on a subscription Issues delivered straight to your door or device ...

as the first and only prescription treatment for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. Zepbound is intended to help alleviate sleep disorders in adults affected ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound (tirzepatide) to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The drug is to be ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Radiofrequency ablation uses radio frequency energy to shrink the tissues in the airway. It is beneficial for minimally invasive procedures with a short recovery time. Full jaw surgery involves moving ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

The two most commonly recognized types of sleep apnea are obstructive and central sleep ... in 2024 for treating moderate or severe OSA in people who also have obesity. Zepbound is the first ...